These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3146502)

  • 41. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
    Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency.
    Borges JL; Blizzard RM; Gelato MC; Furlanetto R; Rogol AD; Evans WS; Vance ML; Kaiser DL; MacLeod RM; Merriam GR; Loriaux DL; Spiess J; Rivier J; Vale W; Thorner MO
    Lancet; 1983 Jul; 2(8342):119-24. PubMed ID: 6134978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth hormone-releasing hormone: therapeutic perspectives.
    Gelato MC; Malozowski S; Pescovitz OH; Cassorla F; Loriaux DL; Merriam GR
    Pediatrician; 1987; 14(3):162-7. PubMed ID: 3134651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of growth hormone deficiencies with growth hormone releasing hormone. Current status and perspectives].
    Auzerie J; Colle M; Guinot P; Lavergne V
    Arch Pediatr; 1995 Apr; 2(4):365-72. PubMed ID: 7780546
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discrimination between growth hormone (GH) deficiency of hypothalamic or pituitary origin: an aid in selecting patients for GH-releasing hormone (RH) prolonged therapy.
    Keret R; Josefsberg Z; Kinarti H; Silbergeld A; Szoke B; Schally AV; Laron Z
    Isr J Med Sci; 1988; 24(4-5):207-11. PubMed ID: 3132434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Testing with growth hormone-releasing factor (GRF(1-29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency.
    Ranke MB; Gruhler M; Rosskamp R; Brügmann G; Attanasio A; Blum WF; Bierich JR
    Eur J Pediatr; 1986 Dec; 145(6):485-92. PubMed ID: 2880720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents.
    Laron Z; Bowers CY; Hirsch D; Almonte AS; Pelz M; Keret R; Gil-Ad I
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):424-6. PubMed ID: 8279223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency.
    Lustig RH; Schriock EA; Kaplan SL; Grumbach MM
    Pediatrics; 1985 Aug; 76(2):274-9. PubMed ID: 3927254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of growth-hormone deficiency with growth-hormone-releasing hormone.
    Ross RJ; Rodda C; Tsagarakis S; Davies PS; Grossman A; Rees LH; Preece MA; Savage MO; Besser GM
    Lancet; 1987 Jan; 1(8523):5-8. PubMed ID: 2879138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of beta 1-adrenergic blockade on the growth response to growth hormone (GH)-releasing hormone therapy in GH-deficient children.
    Cassorla F; Mericq V; García H; Cristiano A; Avila A; Boric A; Iñiguez G; Merriam GR
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2997-3001. PubMed ID: 7559887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature.
    Pihoker C; Badger TM; Reynolds GA; Bowers CY
    J Endocrinol; 1997 Oct; 155(1):79-86. PubMed ID: 9390009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of intraventricular growth hormone-releasing factor on growth hormone release: further evidence for ultrashort loop feedback.
    Lumpkin MD; Samson WK; McCann SM
    Endocrinology; 1985 May; 116(5):2070-4. PubMed ID: 3921349
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exogenous human growth hormone-releasing factor and ovine somatotropin improve growth performance and composition of gain in lambs.
    Beermann DH; Hogue DE; Fishell VK; Aronica S; Dickson HW; Schricker BR
    J Anim Sci; 1990 Dec; 68(12):4122-33. PubMed ID: 2286554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Presence of growth hormone-releasing factor-like immunoreactivity in human cerebrospinal fluid.
    Kashio Y; Chihara K; Kaji H; Minamitani N; Kita T; Okimura Y; Abe H; Iwasaki J; Fujita T
    J Clin Endocrinol Metab; 1985 Feb; 60(2):396-8. PubMed ID: 3917461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Somatocrinin induces growth hormone release in a case of growth hormone deficiency of hypothalamic origin in a child].
    Sassolas G; Rousset H; Cohen R; Chatelain P; Claustrat B; Laporte S; Laferrère B; El Charfi A; Ferry S
    C R Seances Acad Sci III; 1983; 296(11):527-30. PubMed ID: 6409361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults.
    Laursen T; Jørgensen JO; Christiansen JS
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):337-43. PubMed ID: 7525120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alpha 2-adrenergic control of growth hormone (GH) secretion in conscious male rabbits: involvement of endogenous GH-releasing factor and somatostatin.
    Minamitani N; Chihara K; Kaji H; Kodama H; Kita T; Fujita T
    Endocrinology; 1989 Dec; 125(6):2839-45. PubMed ID: 2479528
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Efficacy of GH-releasing hormone and biosynthetic GH in a group of children with growth hormone deficiency].
    Biscaldi I; Fiori A; Moretta A; Valtorta A
    Medicina (Firenze); 1990; 10(2):145-6. PubMed ID: 2273946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Correlation between growth velocity and hematologic levels of somatomedin C during the treatment with growth hormones (GH) in subjects with "classic" and "non-classic" deficits of GH].
    Saggese G; Cesaretti G; Cioni C; Bracaloni C; Giannessi N; Cinquanta L
    Minerva Pediatr; 1993; 45(1-2):7-13. PubMed ID: 8316167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism.
    Takano K; Hizuka N; Shizume K; Asakawa K; Miyakawa M; Hirose N; Shibasaki T; Ling NC
    J Clin Endocrinol Metab; 1984 Feb; 58(2):236-41. PubMed ID: 6420432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.